tirzepatide dosage syringe in dosage: complete guide to choosing, reading, and using the right syringe Dosing for Tirzepatide Compounded Tirzepatide vs. Zepbound –

As of May 2026, the FDA Adverse Event Monitoring System (AEMS) showed 659 reports of alopecia (hair loss) and 389 reports of suicidal ideation

Continuous glucose monitoring, if available, helps track the pace of improvement

In addition, in January 2025, Medicare announced it will include semaglutide products (Ozempic, Rybelsus, and Wegovy) in its second round of drug price negotiations, treating all three brands as a single drug due to their shared active ingredient.28 With negotiated prices set to take effect in 2027, this could significantly reduce costs for Medicare beneficiaries

AP examines what pharmacists need to know